FTC seeks public comments on pharmacy benefit managers' impact on patients, pharmacies

The request for information comes on the heels of the FTC's failed bid to launch a formal inquiry into PBM practices that would have required some of the nation's largest PBMs to turnover information and documents to the agency.


Last week, FTC commissioners were at an impasse on launching an investigation into PBMs' drug-pricing practices and how those practices ultimately "may disadvantage independent or specialty pharmacies," according to last week's agenda.


Read the full story >